Kanniyappan Udayakumar, Wang Bohan, Yang Charles, Ghassemi Pejhman, Litorja Maritoni, Suresh Nitin, Wang Quanzeng, Chen Yu, Pfefer T Joshua
Fischell Department of Bioengineering, University of Maryland, College Park, MD, USA.
Center for Devices and Radiological Health, Food and Drug Administration, Silver Spring, MD, USA.
Med Phys. 2020 Aug;47(8):3389-3401. doi: 10.1002/mp.14189. Epub 2020 Jun 1.
Near-infrared fluorescence (NIRF) imaging using exogenous contrast has gained much attention as a technique for enhancing visualization of vasculature using untargeted agents, as well as for the detection and localization of cancer with targeted agents. In order to address the emerging need for standardization of NIRF imaging technologies, it is necessary to identify the best practices suitable for objective, quantitative testing of key image quality characteristics. Toward the development of a battery of test methods that are rigorous yet applicable to a wide variety of devices, we have evaluated techniques for phantom design, measurement, and calculation of specific performance metrics.
Using a NIRF imaging system for indocyanine green imaging, providing excitation at 780 nm and detection above 830 nm, we explored methods to evaluate uniformity, field of view, spectral crosstalk, spatial resolution, depth of field, sensitivity, linearity, and penetration depth. These measurements were performed using fluorophore-doped multiwell plate and high turbidity planar phantoms, as well as a 3D-printed multichannel phantom and a USAF 1951 resolution target.
Based on a wide range of approaches described in medical and fluorescence imaging literature, we have developed and demonstrated a cohesive battery of test methods for evaluation of fluorescence image quality in wide-field imagers. We also propose a number of key metrics that can facilitate direct, quantitative comparison of device performance. These methods have the potential to facilitate more uniform evaluation and inter-comparison of clinical and preclinical imaging systems than is typically achieved, with the long-term goal of establishing international standards for fluorescence image quality assessment.
使用外源性造影剂的近红外荧光(NIRF)成像作为一种技术,通过非靶向剂增强血管系统的可视化,以及使用靶向剂检测和定位癌症,已备受关注。为了满足对NIRF成像技术标准化的新需求,有必要确定适用于对关键图像质量特征进行客观、定量测试的最佳实践方法。为了开发一系列严格但适用于多种设备的测试方法,我们评估了用于体模设计、测量和特定性能指标计算的技术。
使用用于吲哚菁绿成像的NIRF成像系统,在780 nm处提供激发光并在830 nm以上进行检测,我们探索了评估均匀性、视野、光谱串扰、空间分辨率、景深、灵敏度、线性度和穿透深度的方法。这些测量使用了荧光团掺杂的多孔板和高浊度平面体模,以及3D打印的多通道体模和美国空军1951分辨率靶标。
基于医学和荧光成像文献中描述的广泛方法,我们开发并展示了一套连贯的测试方法,用于评估宽视野成像仪中的荧光图像质量。我们还提出了一些关键指标,可促进对设备性能进行直接、定量的比较。这些方法有可能比通常情况更便于对临床和临床前成像系统进行更统一的评估和相互比较,其长期目标是建立荧光图像质量评估的国际标准。